Cong Huai
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 3
-
- CRISPR and Genetic Engineering 4
-
- Genetic Associations and Epidemiology 4
- Genomics and Rare Diseases 3
-
- Drug Transport and Resistance Mechanisms 3
-
- Renal Transplantation Outcomes and Treatments 2
-
- MicroRNA in disease regulation 2
- Partner nations
- ChinaSouth KoreaThailand
In The Last Decade
Cong Huai
29 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Pharmacology 242
- Business and International Management 27
- Aging 13
- Molecular Biology 493
- Biological Psychiatry 16
Countries citing papers authored by Cong Huai
This map shows the geographic impact of Cong Huai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Huai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Huai more than expected).
Fields of papers citing papers by Cong Huai
This network shows the impact of papers produced by Cong Huai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Huai. The network helps show where Cong Huai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cong Huai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 14 | |
| 12 | 2019 | 19 | |
| 13 | 2018 | 3 | |
| 14 | 2017 | 61 | |
| 15 | 2017 | 112 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 29 | |
| 18 | 2014 | 27 | |
| 19 | 2013 | 14 | |
| 20 | 2012 | 21 |
About Cong Huai
Cong Huai is a scholar working on Transplantation, Business and International Management, Pharmacology, Biological Psychiatry and Genetics, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Genetic Associations and Epidemiology (4 papers), Genomics and Rare Diseases (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Pharmacology (242 citations), Business and International Management (27 citations), Aging (13 citations), Molecular Biology (493 citations) and Biological Psychiatry (16 citations). Cong Huai has collaborated with scholars based in China, South Korea and Thailand. Frequent co-authors include Shengying Qin, Mo Li, Lu Shen, Lin He, Na Zhang, Mingzhe Zhao, Xianglong Zhao, Yingtian Zhang, Jingsong Ma and Bixuan Jiang. Their work appears in journals such as Frontiers in Pharmacology, Scientific Reports, Carcinogenesis, Translational Psychiatry and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.